Iodine Prophylaxis Following Nuclear Accidents

Iodine Prophylaxis Following Nuclear Accidents

Iodine Prophylaxis Following Nuclear Accidents.

Thyroid Cancer and Nuclear Accidents: Long-Term Aftereffects of Chernobyl and Fukushima discusses the radiobiological effects of the release of radioiodine from two nuclear power plant accidents and appropriate interpretation of the results of thyroid ultrasound examination. The book pulls together expert opinion on radiation related thyroid cancer in an understandable manner, even for non thyroidologists. The book explains what has been learned from both accidents in relation to prevention of thyroid cancer following nuclear power plant accidents. The book encompasses topics such as risk estimations of thyroid cancer following nuclear accidents and clinical aspects after those specific situations. Additionally, it discusses in detail the reports from Fukushima related to thyroid cancer in the population. This book is a valuable resource for oncologists and biomedical researchers with interest in nuclear accidents and cancer cases. Offers an overview of the major cancer reports from the Chernobyl and Fukushima disasters Encompasses authoritative data and interpretation of the thyroid screening program in Japan Presents the content in a didactic way to help readers interpret and explain the topic to non-experts Discusses risk estimations of thyroid cancer following nuclear accidents

These guidelines are an update of the 1999 World Health Organization (WHO) guidance on the use of iodine thyroid blocking (ITB) with a special focus on public health considerations of ITB implementation.These guidelines provide a recommendation on iodine thyroid blocking (ITB), via oral administration of stable iodine, as an urgent protective action in responding to a nuclear accident. This recommendation aims to support emergency planners, policy makers, public health specialists, clinicians and other relevant stakeholders, in order to strengthen public health preparedness for radiation emergencies in WHO Member States as required by the International Health Regulations (IHR) and in line with the international safety standards (GSR Part 7). The scope of the guidelines is confined to public health aspects of planning and implementation of ITB before and during a radiation emergency, such as dosage and timing of ITB administration, adverse effects of stable iodine, its packaging, storage, and distribution.

Radioactive iodines are produced during the operation of nuclear power plants and during the detonation of nuclear weapons. In the event of a radiation incident, radioiodine is one of the contaminants that could be released into the environment. Exposure to radioiodine can lead to radiation injury to the thyroid, including thyroid cancer. Radiation to the thyroid from radioiodine can be limited by taking a nonradioactive iodine (stable iodine) such as potassium iodide. This book assesses strategies for the distribution and administration of potassium iodide (KI) in the event of a nuclear incident. The report says that potassium iodide pills should be available to everyone age 40 or youngerâ€"especially children and pregnant and lactating womenâ€"living near a nuclear power plant. States and municipalities should decide how to stockpile, distribute, and administer potassium iodide tablets, and federal agencies should keep a backup supply of tablets and be prepared to distribute them to affected areas.

Radioactive iodines are produced during the operation of nuclear power plants and during the detonation of nuclear weapons. In the event of a radiation incident, radioiodine is one of the contaminants that could be released into the environment. Exposure to radioiodine can lead to radiation injury to the thyroid, including thyroid cancer. Radiation to the thyroid from radioiodine can be limited by taking a nonradioactive iodine (stable iodine) such as potassium iodide. This book assesses strategies for the distribution and administration of potassium iodide (KI) in the event of a nuclear incident. The report says that potassium iodide pills should be available to everyone age 40 or youngerâ€"especially children and pregnant and lactating womenâ€"living near a nuclear power plant. States and municipalities should decide how to stockpile, distribute, and administer potassium iodide tablets, and federal agencies should keep a backup supply of tablets and be prepared to distribute them to affected areas.